Sieger M, Morin J, Budris L, Sienna M, Ostfeld-Johns S, Hart L
Matern Child Health J. 2024; 28(6):1121-1131.
PMID: 38539033
PMC: 11060901.
DOI: 10.1007/s10995-024-03914-6.
Bruzelius E, Underhill K, Askari M, Kajeepeta S, Bates L, Prins S
Int J Drug Policy. 2024; 126:104380.
PMID: 38484529
PMC: 11056296.
DOI: 10.1016/j.drugpo.2024.104380.
Flannigan K, Murphy L, Pei J
Subst Abuse. 2023; 17:11782218231208980.
PMID: 37954218
PMC: 10637139.
DOI: 10.1177/11782218231208980.
Peltier M, Roberts W, Verplaetse T, Burke C, Zakiniaeiz Y, Moore K
Arch Womens Ment Health. 2022; 25(4):819-827.
PMID: 35737132
PMC: 9359119.
DOI: 10.1007/s00737-022-01244-6.
Cestonaro C, Menozzi L, Terranova C
Children (Basel). 2022; 9(1).
PMID: 35053692
PMC: 8774427.
DOI: 10.3390/children9010067.
Mothering from the Inside Out: Addressing the Intersection of Addiction, Adversity, and Attachment with Evidence-Based Parenting Intervention.
Lowell A, Peacock-Chambers E, Zayde A, DeCoste C, McMahon T, Suchman N
Curr Addict Rep. 2021; 8(4):605-615.
PMID: 34306964
PMC: 8280593.
DOI: 10.1007/s40429-021-00389-1.
Patterns of polydrug use among pregnant substance abusers.
Reitan T
Nordisk Alkohol Nark. 2020; 34(2):145-159.
PMID: 32934478
PMC: 7450863.
DOI: 10.1177/1455072516687256.
"They look at us like junkies": influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City.
Muncan B, Walters S, Ezell J, Ompad D
Harm Reduct J. 2020; 17(1):53.
PMID: 32736624
PMC: 7393740.
DOI: 10.1186/s12954-020-00399-8.
Antepartum Drug Dependence and Pregnancy- or Birth-related Complications: A Cross-sectional Study of 19 Million Inpatients.
Ahmad N, Robert C, Jampa A, Ashraf S, Patel R
Cureus. 2019; 11(11):e6117.
PMID: 31886056
PMC: 6903893.
DOI: 10.7759/cureus.6117.
Beliefs and Behaviors of Pregnant Women with Addictions Awaiting Treatment Initiation.
Van Scoyoc A, Harrison J, Fisher P
Child Adolesc Social Work J. 2019; 34(1):65-79.
PMID: 31588163
PMC: 6777720.
DOI: 10.1007/s10560-016-0474-0.
Prenatal Practice Staff Perceptions of Three Substance Use Screening Tools for Pregnant Women.
Trocin K, Weinstein N, Oga E, Mark K, Coleman-Cowger V
J Addict Med. 2019; 14(2):139-144.
PMID: 31090554
PMC: 6842409.
DOI: 10.1097/ADM.0000000000000543.
Factors associated with treatment retention in pregnant women with opioid use disorders prescribed methadone or electing non-pharmacological treatment.
Jancaitis B, Kelpin S, Masho S, May J, Haug N, Svikis D
Women Health. 2019; 60(1):1-11.
PMID: 31068095
PMC: 6842074.
DOI: 10.1080/03630242.2019.1610829.
Obstetric and Pediatric Provider Perspectives on Mandatory Reporting of Prenatal Substance Use.
Jarlenski M, Minney S, Hogan C, Chang J
J Addict Med. 2018; 13(4):258-263.
PMID: 30550393
PMC: 10015980.
DOI: 10.1097/ADM.0000000000000489.
Neuroendocrine and immune pathways from pre- and perinatal stress to substance abuse.
Horn S, Roos L, Berkman E, Fisher P
Neurobiol Stress. 2018; 9:140-150.
PMID: 30450380
PMC: 6236513.
DOI: 10.1016/j.ynstr.2018.09.004.
Multigenerational and transgenerational effects of paternal exposure to drugs of abuse on behavioral and neural function.
Goldberg L, Gould T
Eur J Neurosci. 2018; 50(3):2453-2466.
PMID: 29949212
PMC: 7296771.
DOI: 10.1111/ejn.14060.
Judging the Neonatal Abstinence Syndrome Assessment Tools to Guide Future Tool Development: The use of Clinimetrics as Opposed to Psychometrics.
Westgate P, Gomez-Pomar E
Front Pediatr. 2017; 5:204.
PMID: 28979894
PMC: 5611403.
DOI: 10.3389/fped.2017.00204.
Characterization of U.S. State Laws Requiring Health Care Provider Reporting of Perinatal Substance Use.
Jarlenski M, Hogan C, Bogen D, Chang J, Bodnar L, Van Nostrand E
Womens Health Issues. 2017; 27(3):264-270.
PMID: 28129942
PMC: 5435508.
DOI: 10.1016/j.whi.2016.12.008.
Managing Maternal Substance Use in the Perinatal Period: Current Concerns and Treatment Approaches in the United States and Australia.
Burns L, Coleman-Cowger V, Breen C
Subst Abuse. 2016; 10(Suppl 1):55-61.
PMID: 27980414
PMC: 5147518.
DOI: 10.4137/SART.S34558.
Structural stigma: Research evidence and implications for psychological science.
Hatzenbuehler M
Am Psychol. 2016; 71(8):742-751.
PMID: 27977256
PMC: 5172391.
DOI: 10.1037/amp0000068.
The Prevalence and Impact of Substance Use Disorder and Treatment on Maternal Obstetric Experiences and Birth Outcomes Among Singleton Deliveries in Massachusetts.
Kotelchuck M, Cheng E, Belanoff C, Cabral H, Babakhanlou-Chase H, Derrington T
Matern Child Health J. 2016; 21(4):893-902.
PMID: 27832443
PMC: 5380534.
DOI: 10.1007/s10995-016-2190-y.